Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127543841 | 12754384 | 1 | I | 20160912 | 20160916 | 20160916 | EXP | PHJP2016JP026041 | NOVARTIS | 69.00 | YR | M | Y | 0.00000 | 20160916 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127543841 | 12754384 | 1 | PS | NEORAL | CYCLOSPORINE | 1 | Unknown | 50 MG, QD | 50715 | 50 | MG | CAPSULE | QD | ||||||
127543841 | 12754384 | 2 | SS | NEORAL | CYCLOSPORINE | 1 | Unknown | 200-250 MG, UNK | 50715 | 250 | MG | CAPSULE | QD | ||||||
127543841 | 12754384 | 3 | SS | NEORAL | CYCLOSPORINE | 1 | Unknown | 250 MG, UNK | 50715 | 250 | MG | CAPSULE |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127543841 | 12754384 | 1 | Still's disease adult onset |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127543841 | 12754384 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127543841 | 12754384 | Alanine aminotransferase increased | |
127543841 | 12754384 | Arthropathy | |
127543841 | 12754384 | C-reactive protein increased | |
127543841 | 12754384 | Product use issue | |
127543841 | 12754384 | Pyrexia | |
127543841 | 12754384 | Serum ferritin increased | |
127543841 | 12754384 | Still's disease adult onset |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |